Multiple myeloma, version 1.2020 featured updates to the NCCN guidelines

Shaji K. Kumar, Natalie S. Callander, Jens Hillengass, Michaela Liedtke, Muhamed Baljevic, Erica Campagnaro, Jorge J. Castillo, Jason C. Chandler, Robert F. Cornell, Caitlin Costello, Yvonne Efebera, Matthew Faiman, Alfred Garfall, Kelly Godby, Leona Holmberg, Myo Htut, Carol Ann Huff, Yubin Kang, Ola Landgren, Ehsan MalekThomas Martin, James Omel, Noopur Raje, Douglas Sborov, Seema Singhal, Keith Stockerl-Goldstein, Carlyn Tan, Donna Weber, Alyse Johnson-Chilla, Jennifer Keller, Rashmi Kumar

Research output: Contribution to journalReview articlepeer-review

115 Scopus citations

Abstract

The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance, solitary plasmacytoma, smoldering myeloma, and multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates and changes in the 1.2020 version of the NCCN Guidelines for Multiple Myeloma.

Original languageEnglish (US)
Pages (from-to)1154-1165
Number of pages12
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume17
Issue number10
DOIs
StatePublished - 2019

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Multiple myeloma, version 1.2020 featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this